The WACC of Biostar Pharmaceuticals Inc (BSPM) is 3.3%.
| Range | Selected | |
| Cost of equity | 3.30% - 313.00% | 158.15% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 4.50% - 4.50% | 4.50% |
| WACC | 3.3% - 3.3% | 3.3% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | -66.53 | 0.47 |
| Additional risk adjustments | 305.5% | 306.0% |
| Cost of equity | 3.30% | 313.00% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 8819.26 | 8819.26 |
| Cost of debt | 4.50% | 4.50% |
| After-tax WACC | 3.3% | 3.3% |
| Selected WACC | 3.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BSPM:
cost_of_equity (158.15%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (-66.53) + risk_adjustments (305.75%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.